View Jeff's WaterWorks' Articles BY TICKER:
What To Expect From VirnetX's En Banc Appeal
- A mixed decision at the CAFC sent VirnetX's stock price to 52 week lows.
- With all four patents found not invalid and Apple found to infringe with its VPN on Demand feature, those lows are not warranted.
- Damages were remanded, not dismissed. A new trial will allow VirnetX to once again establish damages awarded by a jury by following the guidelines from the CAFC.
VirnetX Vs. Apple At The CAFC: Why VirnetX Seeks En Banc Review, Why Apple Does Not
- A clear district court win for VirnetX vs. Apple turns into a mixed bag at the CAFC, but the bag is still well over half full.
- VirnetX seeks to have restored a $368 MM jury damages award and a finding of FaceTime infringing its patents.
- A clear over-reaction to the CAFC's opinion has left VirnetX's stock underpriced.
VirnetX Vs. Apple At The CAFC: What Was Said And Why
- VirnetX's day at the CAFC was not at all what you might think by looking at its recent stock performance.
- The recent stock performance offers investors an opportunity to get into the stock at an opportune price.
- Opportune prices don't always present themselves again.
VirnetX Vs. Apple At The CAFC: Why VirnetX Will Be Just Fine
- VirnetX received a favorable ongoing royalty ruling versus Apple potentially paying them $300MM+ annually.
- The CAFC hearing of Apple's appeal of the original case occurred several days later, and the lines of questioning brought up many valid concerns and rampant speculation.
- Proper due diligence can put a lot of this rampant speculation to rest and demonstrate that this company is a great buy at these prices.
- With the adjudicated ongoing royalty rate in hand, VirnetX is poised to sign non-litigant licensees and increase earnings exponentially.